BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14567021)

  • 1. Impact of perioperative intraperitoneal chemotherapy on the treatment of primary gastric cancer.
    Yu W
    Surg Oncol Clin N Am; 2003 Jul; 12(3):623-34, xi. PubMed ID: 14567021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
    Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
    Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective therapy for peritoneal dissemination in gastric cancer.
    Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Endou Y; Sasaki T
    Surg Oncol Clin N Am; 2003 Jul; 12(3):635-48. PubMed ID: 14567022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer.
    Noh SH; Yoo CH; Chung HC; Roh JK; Shin DW; Min JS
    Oncology; 2001; 60(1):24-30. PubMed ID: 11150904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New drugs for treatment of gastric cancer.
    Schöffski P
    Ann Oncol; 2002; 13 Suppl 4():13-22. PubMed ID: 12401661
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of intraperitoneal and intravenous chemotherapy and left upper abdominal evisceration for advanced gastric cancer.
    Nomura E; Niki M; Fujii K; Shinohara H; Nishiguchi K; Sonoda T; Tanigawa N
    Gastric Cancer; 2001; 4(2):75-82. PubMed ID: 11706764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials.
    Coccolini F; Cotte E; Glehen O; Lotti M; Poiasina E; Catena F; Yonemura Y; Ansaloni L
    Eur J Surg Oncol; 2014 Jan; 40(1):12-26. PubMed ID: 24290371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
    Yu W
    Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.
    Shi C; Yang B; Chen Q; Yang J; Fan N
    Oncology; 2011; 80(5-6):289-95. PubMed ID: 21778768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial.
    Yu W; Whang I; Chung HY; Averbach A; Sugarbaker PH
    World J Surg; 2001 Aug; 25(8):985-90. PubMed ID: 11571980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant intraperitoneal chemotherapy for advanced primary gastric cancer.
    Sugarbaker PH
    Scand J Surg; 2006; 95(4):270-3. PubMed ID: 17249276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy.
    Coccolini F; Fugazzola P; Ansaloni L; Sartelli M; Cicuttin E; Leandro G; De' Angelis GL; Gaiani F; Di Mario F; Tomasoni M; Catena F
    Acta Biomed; 2018 Dec; 89(8-S):104-109. PubMed ID: 30561427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies.
    Katz MH; Barone RM
    Surg Oncol Clin N Am; 2003 Jul; 12(3):673-88. PubMed ID: 14567024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer.
    Yan TD; Black D; Sugarbaker PH; Zhu J; Yonemura Y; Petrou G; Morris DL
    Ann Surg Oncol; 2007 Oct; 14(10):2702-13. PubMed ID: 17653801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials.
    Sun J; Song Y; Wang Z; Gao P; Chen X; Xu Y; Liang J; Xu H
    BMC Cancer; 2012 Nov; 12():526. PubMed ID: 23153379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
    Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG
    Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy in gastric cancer: can we prevent recurrences?
    Meyerhardt JA; Fuchs CS
    Oncology (Williston Park); 2003 May; 17(5):714-21, 728; discussion 728-9, 732-3. PubMed ID: 12800796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer.
    Yu W; Whang I; Suh I; Averbach A; Chang D; Sugarbaker PH
    Ann Surg; 1998 Sep; 228(3):347-54. PubMed ID: 9742917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
    Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
    Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer.
    Chipponi J; Huguier M; Pezet D; Basso N; Hay JM; Quandalle P; Jaeck D; Fagniez PL; Gainant A
    Am J Surg; 2004 Mar; 187(3):440-5. PubMed ID: 15006580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.